HomeBST • BME
add
Biotechnology Assets SA
Previous close
€0.30
Day range
€0.29 - €0.30
Year range
€0.28 - €0.46
Market cap
19.02M EUR
Avg Volume
66.28K
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.13M | 26.02% |
Operating expense | 1.19M | 13.61% |
Net income | -689.76K | -208.44% |
Net profit margin | -60.87 | -144.75% |
Earnings per share | — | — |
EBITDA | 52.58K | 34.68% |
Effective tax rate | -119.64% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 416.87K | -47.92% |
Total assets | 16.61M | -10.11% |
Total liabilities | 10.08M | -30.99% |
Total equity | 6.53M | — |
Shares outstanding | 57.73M | — |
Price to book | 2.53 | — |
Return on assets | -2.93% | — |
Return on capital | -4.57% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -689.76K | -208.44% |
Cash from operations | 491.67K | -5.22% |
Cash from investing | 108.36K | 112.51% |
Cash from financing | -571.69K | -52.53% |
Net change in cash | 28.34K | 103.92% |
Free cash flow | 359.62K | 173.26% |
About
Founded
1954
Website
Employees
37